Related Experiment Video
Updated: Jul 18, 2026
The Aortic Ring Co-culture Assay: A Convenient Tool to Assess the Angiogenic Potential of Mesenchymal Stromal Cells In Vitro
Published on: September 18, 2017
Pathology of Transmyocardial Angiogenesis and Arteriogenesis
1Department of Cardiovascular Pathology, Armed Forces Institute of Pathology, 6825 16th Street, NW, Washington, DC 20306, USA.
Insights
Transmyocardial laser revascularization (TMLR) efficacy is debated. Research suggests focusing on arteriogenesis, the formation of larger collateral vessels, may be key to improving outcomes in ischemic heart disease.
Area of Science:
- Cardiovascular Surgery
- Regenerative Medicine
- Medical Technology
Background:
- Transmyocardial laser revascularization (TMLR) is used for diffuse coronary artery disease.
- Its clinical efficacy, particularly regarding increased blood flow and patient longevity, remains uncertain.
- Histological findings show limited neocapillary formation, similar to natural processes post-myocardial infarction.
Purpose of the Study:
- To evaluate the effectiveness of TMLR in improving myocardial perfusion.
- To investigate the underlying mechanisms of vascularization following TMLR.
- To explore alternative vascularization strategies, such as arteriogenesis, for refractory ischemia.
Main Methods:
- Review of histological data from TMLR procedures.
- Comparison of angiogenesis post-TMLR with natural myocardial infarction healing.
- Analysis of experimental studies on collateral vessel formation (arteriogenesis).
Main Results:
- TMLR demonstrates limited neocapillary formation, comparable to natural angiogenesis after myocardial infarction.
- The sufficiency of these capillaries for maintaining myocardial viability is questioned.
- Experimental evidence suggests feasibility in inducing collateral vessel formation (arteriogenesis).
Conclusions:
- The clinical benefit of TMLR requires further validation, as significant increases in blood flow or longevity are not definitively proven.
- Arteriogenesis, rather than solely angiogenesis, may be a more promising mechanism for improving outcomes in ischemic heart disease.
- Further research into the factors regulating arteriogenesis and methods for its clinical and experimental documentation is critical.
Abstract:
Transmyocardial laser revascularization (TMLR) is increasingly used for improving myocardial perfusion in patients with diffuse coronary artery disease and refractory ischemia. The efficacy of TMLR, however, is in doubt because no definite increase in blood flow or longevity has been demonstrated. Although histologic results after TMLR show some neocapillary formation, the relative amount of angiogenesis is similar to what occurs naturally after myocardial infarction. Hence, it is suspected that these few capillaries would be sufficient to maintain a viable myocardium. Alternatively, the creation of collateral vessel "arteriogenesis" rather than capillary formation alone may improve the clinical outcome. Comprehensive experimental studies seem to indicate the feasibility of producing new collaterals. This method of vascularization is dependent upon specific cytokines or enzymes that induce proliferation of native arterial endothelial cells and smooth muscle cells. It is critical that we develop a better understanding of which factors regulate arteriogenesis, and concentrate on methods to document its existence in the clinical and experimental setting.
Related Concept Videos
01:10Mechanism of Angiogenesis
01:24Regulation of Angiogenesis and Blood Supply
01:21Myocarditis I: Introduction
01:26Coronary Artery Disease II: Pathophysiology
01:30Atherosclerosis I: Introduction